Anbio Biotechnology (NNNN) CFO files Form 3 insider ownership report

Rhea-AI Filing Summary

Anbio Biotechnology CFO Song Suki has filed an initial insider ownership report on Form 3 for ticker NNNN. The filing establishes her status as an officer but does not report any insider buy, sell, or other share transactions in this submission.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Song Suki

(Last) (First) (Middle)

FRIEDRICH-EBERT-ANLAGE 35-37

(Street)

FRANKFURT AM MAIN 60327

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Anbio Biotechnology [ NNNN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Suki Song	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Anbio Biotechnology (NNNN) CFO Song Suki’s Form 3 filing mean?

It is an initial insider ownership report for CFO Song Suki at Anbio Biotechnology (NNNN). Form 3 establishes her reporting status as an officer but, in this case, does not list any insider share transactions.

Does the Anbio Biotechnology (NNNN) Form 3 show any insider buying or selling?

No insider buying or selling is reported in this Form 3 for Anbio Biotechnology (NNNN). The transaction summary shows zero buys, zero sells, and no derivative transactions for CFO Song Suki in this filing.

Who is the insider named in the Anbio Biotechnology (NNNN) Form 3?

The insider is Song Suki, who serves as Chief Financial Officer (CFO) of Anbio Biotechnology (NNNN). The filing confirms her officer role and begins ongoing insider reporting obligations under SEC rules.

Does this Anbio Biotechnology (NNNN) Form 3 include any option or derivative positions?

The Form 3 data for Anbio Biotechnology (NNNN) shows no listed derivative positions. The derivative summary is empty and the transaction summary reports zero derivative transactions for CFO Song Suki in this filing.

Why is a Form 3 important for Anbio Biotechnology (NNNN) investors?

Form 3 signals that a company insider like CFO Song Suki is now subject to ongoing disclosure of future trades. While this filing shows no transactions, later Forms 4 and 5 will report her reportable share dealings.